| 000 | 01534 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250511182628.0 | ||
| 264 | 0 | _c19921102 | |
| 008 | 199211s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/BF00685597 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDamia, G | |
| 245 | 0 | 0 |
_aActivity of aphidicolin glycinate alone or in combination with cisplatin in a murine ovarian tumor resistant to cisplatin. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c1992 |
||
| 300 |
_a459-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aAphidicolin _xadministration & dosage |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 700 | 1 | _aTagliabue, G | |
| 700 | 1 | _aZucchetti, M | |
| 700 | 1 | _aDavoli, E | |
| 700 | 1 | _aSessa, C | |
| 700 | 1 | _aCavalli, F | |
| 700 | 1 | _aD'Incalci, M | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 30 _gno. 6 _gp. 459-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00685597 _zAvailable from publisher's website |
| 999 |
_c1401295 _d1401295 |
||